The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Perspective Therapeutics Inc shares valued at $22,814 were purchased by Williamson Robert F III on Nov 25 ’24. At $3.64 per share, Williamson Robert F III acquired 6,266 shares. The insider’s holdings grew to 430,058 shares worth approximately $1.77 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Hunt Jonathan Robert purchased 12,829 shares, netting a total of over 48,974 in proceeds. Following the buying of shares at $3.82 each, the insider now holds 48,800 shares.
Before that, Spoor Johan M. had added 14,500 shares to its account. In a trade valued at $54,868, the CEO bought Perspective Therapeutics Inc shares for $3.78 each. Upon closing the transaction, the insider’s holdings increased to 14,500 shares, worth approximately $0.63 million.
As published in a research note from BofA Securities on November 25, 2024, Perspective Therapeutics Inc [CATX] has been rated down from a Buy to a Neutral and the price target has been revised to $5 from $24. Analysts at UBS started covering the stock with ‘”a Buy”‘ outlook in a report released in late October. As of October 01, 2024, Wedbush has initiated its “an Outperform” rating for CATX. Earlier on September 25, 2024, Truist initiated its rating. Their recommendation was “a Buy” for CATX stock.
Analyzing CATX Stock Performance
During the last five days, there has been a drop of approximately -33.23%. Over the course of the year, Perspective Therapeutics Inc shares have jumped approximately 2.49%. Shares of the company reached a 52-week high of $19.05 on 05/15/24 and a 52-week low of $2.94 on 11/22/24. A 50-day SMA is recorded $10.96, while a 200-day SMA reached $12.67. Nevertheless, trading volume fell to 2.24 million shares from 5.77 million shares the previous day.
Support And Resistance Levels for Perspective Therapeutics Inc (CATX)
According to the 24-hour chart, there is a support level at 3.95, which, if violated, would cause prices to drop to 3.77. In the upper region, resistance lies at 4.47. The next price resistance is at 4.81. RSI (Relative Strength Index) is 22.48 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.95, which suggests the price will decrease in the coming days. Percent R is at 86.73%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
